Sign In
Buy PRQR
$1.72
-0.0600 (-3.37%)
At Close: Jul 31, 2026
ProQR Announces Positive Results from Clinical Trial of QR-421a in Usher Syndrome and Plans to Start Pivotal Trials
07:00am, Wednesday, 24'th Mar 2021
LEIDEN, Netherlands & CAMBRIDGE, Mass., March 24, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of tra
FDA Decisions For Pfizer, Eli Lilly And Bluebird Bio, Bristol-Meyers Squibb, Plus New Data And Earnings
09:52am, Saturday, 20'th Mar 2021
Biotech stocks reversed course in the week ended March 19 amid mixed news flow on data readouts and lackluster broader market performance. Rubius Therapeutics, Inc. (NASDAQ: RUBY) was among the bigges
ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Global Life Sciences Conference
04:30pm, Tuesday, 02'nd Mar 2021
LEIDEN, Netherlands & CAMBRIDGE, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of tra
ProQR Announces Fourth Quarter and Full Year 2020 Operating and Financial Results
07:00am, Thursday, 25'th Feb 2021
LEIDEN, Netherlands & CAMBRIDGE, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of tran
ProQR Announces Expert Perspectives Call on Disease Education and Endpoints in Usher Syndrome
04:30pm, Tuesday, 16'th Feb 2021
LEIDEN, Netherlands & CAMBRIDGE, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of tran
ProQR Announces Webcast of Presentation at Upcoming HC Wainwright BIOCONNECT Conference
07:00am, Friday, 18'th Dec 2020
LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 18, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of tran
ProQR to Present at 3rd Annual Evercore ISI Virtual HealthCONx Conference
07:00am, Wednesday, 18'th Nov 2020
LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 18, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of tran
ProQR Announces Third Quarter 2020 Operating and Financial Results
07:00am, Monday, 16'th Nov 2020
LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of tran
ProQR Announces Virtual Presentations at American Academy of Ophthalmology (AAO)
07:00am, Monday, 02'nd Nov 2020
LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA thera
